Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics

Gene replacement therapy with oncosuppressor microRNAs (miRNAs) is a promising alternative to interfere with cancer progression. However, miRNAs are highly inefficient in a biological environment, hampering a successful translation to clinics. Nanotechnology can tackle this drawback by providing del...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagachinta, Surasa, Bouzo, Belen Lopez, Vazquez-Rios, Abi Judit, Lopez, Rafael, de la Fuente, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076701/
https://www.ncbi.nlm.nih.gov/pubmed/32098309
http://dx.doi.org/10.3390/pharmaceutics12020189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076701/
https://www.ncbi.nlm.nih.gov/pubmed/32098309
http://dx.doi.org/10.3390/pharmaceutics12020189

Ejemplares similares